[N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].

Autor: Kirillova IG; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Novikova DS; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Popkova TV; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Aleksandrova EN; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Novikov AA; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Gorbunova YN; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Markelova EI; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Korsakova YO; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Glukhova SI; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Volkov AV; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Luchikhina EL; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Demidova NV; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Kasumova KA; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Vladimirov SA; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Kanonirova MA; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Lukina GL; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Karateev DE; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia., Nasonov EL; V.A. Nasonova Research Institute of Rheumatology, Moscow, Russia.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2016; Vol. 88 (5), pp. 19-26.